Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

295 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Chemical pleurodesis for malignant pleural effusions.
Walker-Renard PB, Vaughan LM, Sahn SA. Walker-Renard PB, et al. Among authors: sahn sa. Ann Intern Med. 1994 Jan 1;120(1):56-64. doi: 10.7326/0003-4819-120-1-199401010-00010. Ann Intern Med. 1994. PMID: 8250457 Review.
Pleural diseases.
Sahn SA. Sahn SA. Semin Respir Crit Care Med. 2010 Dec;31(6):647-8. doi: 10.1055/s-0030-1269825. Epub 2011 Jan 6. Semin Respir Crit Care Med. 2010. PMID: 21213197 No abstract available.
Dasatinib-induced pleural effusions: a lymphatic network disorder?
Goldblatt M, Huggins JT, Doelken P, Gurung P, Sahn SA. Goldblatt M, et al. Among authors: sahn sa. Am J Med Sci. 2009 Nov;338(5):414-7. doi: 10.1097/MAJ.0b013e3181ae9227. Am J Med Sci. 2009. PMID: 19838099
It binds to both active and inactive conformations of the ABL gene and is 325 times more potent than imatinib in inhibiting the growth of BCR/ABL cells in vitro (Morelock and Sahn, Chest 1999;116:212-21; Huggins and Sahn, Clin Chest Med 2004;25:141-53). Although das …
It binds to both active and inactive conformations of the ABL gene and is 325 times more potent than imatinib in inhibiting the growth of BC …
295 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page